These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24473959)

  • 1. Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents.
    Ued Fda V; Weffort VR
    Rev Paul Pediatr; 2013 Dec; 31(4):523-30. PubMed ID: 24473959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review.
    Caro-Sabido EA; Larrosa-Haro A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):185-194. PubMed ID: 31101468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis.
    Utz-Melere M; Targa-Ferreira C; Lessa-Horta B; Epifanio M; Mouzaki M; Mattos AA
    Ann Hepatol; 2018; 17(3):345-354. PubMed ID: 29735796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
    Wei J; Lei GH; Fu L; Zeng C; Yang T; Peng SF
    PLoS One; 2016; 11(1):e0147985. PubMed ID: 26824361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
    Ji HF; Sun Y; Shen L
    Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
    Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA;
    Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease.
    Panera N; Barbaro B; Della Corte C; Mosca A; Nobili V; Alisi A
    Nutr Res; 2018 Oct; 58():1-16. PubMed ID: 30340810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.
    Mathew MC; Ervin AM; Tao J; Davis RM
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD004567. PubMed ID: 22696344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ; Yi DY; Yang HR
    J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.
    Georgoulis M; Fragopoulou E; Kontogianni MD; Margariti A; Boulamatsi O; Detopoulou P; Tiniakos D; Zafiropoulou R; Papatheodoridis G
    Nutr Res; 2015 Jan; 35(1):41-8. PubMed ID: 25530013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case - Control study.
    Lotfi A; Saneei P; Hekmatdost A; Salehisahlabadi A; Shiranian A; Ghiasvand R
    Clin Nutr ESPEN; 2019 Dec; 34():45-49. PubMed ID: 31677710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.
    Jonscher KR; Stewart MS; Alfonso-Garcia A; DeFelice BC; Wang XX; Luo Y; Levi M; Heerwagen MJ; Janssen RC; de la Houssaye BA; Wiitala E; Florey G; Jonscher RL; Potma EO; Fiehn O; Friedman JE
    FASEB J; 2017 Apr; 31(4):1434-1448. PubMed ID: 28007783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.
    Pydyn N; Miękus K; Jura J; Kotlinowski J
    Pharmacol Rep; 2020 Feb; 72(1):1-12. PubMed ID: 32016853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
    Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO
    Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
    Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
    JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.